LAB Q1 2023 Earnings — Standard BioTools Inc. Revenue & Financial Results | Market Cap Arena

LABStandard BioTools Inc.

$388M

Q1 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$25M-5.2% YoY

Gross Profit

$12M48.9% margin

Operating Income

-$17M-66.1% margin

Net Income

-$17M-67.1% margin

EPS (Diluted)

$-0.21

QoQ Revenue Growth

-7.0%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$9M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$372M

Total Liabilities

$469M

Stockholders' Equity

-$97M

Cash & Equivalents

$114M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$25M	$27M	-5.2%
Gross Profit	$12M	$12M	+0.4%
Operating Income	-$17M	-$28M	+39.7%
Net Income	-$17M	-$76M	+77.9%

Geographic Segments

Americas

$12M46%

EMEA

$8M31%

Asia Pacific

$6M22%